Loading...
Dernières publications
-
Luce Barbat Du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, et al.. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. European Journal of Neurology, 2023, 30 (10), pp.3265-3276. ⟨10.1111/ene.15937⟩. ⟨hal-04254200⟩
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
Corinna Preuße, Barbara Paesler, Christopher Nelke, Derya Cengiz, Thomas Müntefering, et al.. Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta Neuropathologica, 2022, 144 (2), pp.353-372. ⟨10.1007/s00401-022-02438-z⟩. ⟨hal-03830925⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-03832478⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-04002766⟩
-
Stéphane Ederhy, Perrine Devos, Bruno Pinna, Elisa Funck-Brentano, Baptiste Abbar, et al.. 8 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography imaging for the diagnosis of immune checkpoint inhibitors associated myocarditis. Archives of cardiovascular diseases, 2022, ⟨10.1016/j.acvd.2021.12.001⟩. ⟨hal-03561783⟩
-
Pierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, Matthieu Mahevas, Nicolas de Prost, et al.. Plasma exchange are not associated with better outcome in MDA5 rapidly-progressive interstitial lung disease. French Intensive Care Society International Congress 2022, 2022, paris, France. pp.54, ⟨10.1186/s13613-022-01016-6⟩. ⟨hal-03831253⟩
Chiffres clés
123
Publications avec texte intégral
Open Access
53 %
Mots clés
Sphingosine-1-phosphate
AAV antibody
Anémie hémolytique
Cytokines
Adverse drug reactions
Bioelectrical impedance analysis
Case reports
Middle Aged
Inflammation
Biopsy
B-lymphocyte
Analyses multidimensionnelles
Deep immune profiling
Humans
Lysosomal storage diseases
Myopathy
Adult
AAV vector
Dependovirus/genetics/immunology
Mass cytometry
Biomarkers
Antibodies
Anti-agalsidase antibodies
Arthritis
IMNM
Myositis
Biomarker
Fabry disease
Cardio-oncology
AAV humoral immunity
Adeno-associated vector
Anti-interleukin-6
Anti-synthetase syndrome
Acid-alpha-glucosidase
Adeno-associated virus
Machine learning
Abnormal movement
Antibody responses
Anti-IgE IgG
Aged
Muscle
Immunotherapy
Anti-Mi2
Antisynthetase syndrome
Interferon
Aldostérone
Antisynthetase
Inclusion body myositis
IBM
Autoantibody
Assisted communication devices
Cancer
Antisynthétase
Polymyositis
Inflammatory myopathy
Inborn errors of metabolism
Autoantibodies
Biomarqueurs
Myositis and muscle disease
Female
Agalsidase
Anticorps spécifique des myosites
Adolescence
Dermatomyositis
Outcome measures
Active
Pharmacology
Systems biology
Anticorps anti-agalsidase
Auto‐antibodies
DM
Amyotrophy
Animals
B cell homeostasis
Multidisciplinarity
Data integration
COVID-19
Prognosis
Autoimmunity
Anti‐mitochondrial antibodies
Antiphospholipid syndrome
Gene therapy
Auto-immunité
Anti-drug antibodies
Skeletal muscle
AAV
Acute Kidney Injury/epidemiology/etiology
AAV vectors
Adeno-associated virus vector
Idiopathic inflammatory myopathies
Adjudication
Autoimmune diseases
Interstitial lung disease
Anti-MDA5 autoantibodies
Male
Auto-antibodies
Myocarditis
Aldosterone
Amyotrophic lateral sclerosis
Immune checkpoint inhibitors